Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 27;17(7):105833.
doi: 10.4240/wjgs.v17.i7.105833.

Functional paraganglioma of the pancreatic head: A case report and review of literature

Affiliations
Case Reports

Functional paraganglioma of the pancreatic head: A case report and review of literature

Shang-Zheng Luo et al. World J Gastrointest Surg. .

Abstract

Background: Pheochromocytoma and paraganglioma (PGL) are a rare group of neuroendocrine neoplasms with characteristic genetic diversity and catecholamine secretion patterns. They arise from non-neuronal and non-epithelial neuroendocrine cells of the paraganglia, and have the highest rate of heritability among all tumors.

Case summary: A 76-year-old woman presented with the complaint of dizziness that had persisted for one week. She had a 30-year history of hypertension. Despite long-term use of antihypertensive drugs, her blood pressure was not effectively controlled. A tumor was subsequently found in the head of the pancreas by computed tomography and magnetic resonance imaging and she was initially diagnosed with an aneurysm. On December 21, 2021, she underwent resection of the retroperitoneal tumor and pancreatic repair surgery. However, after postoperative pathological analysis and immunohistochemistry, the diagnosis was revised to PGL. After two years and eight months of follow-up, the tumor did not recur or metastasize, and her blood pressure returned to normal without taking antihypertensive drugs.

Conclusion: The possibility of PGL should be considered when a tumor is identified and patients have catecholamine secretion related symptoms that are difficult to control with medications.

Keywords: Case report; Immunohistochemistry; Metanephrines; Pancreatic paraganglioma; Pancreatic tumor; Paraganglioma.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Computed tomography and magnetic resonance imaging findings. A: A Non-contrast-enhanced computed tomography scan showing a mass of approximately 3.2 cm × 4.1 cm × 5.0 cm in size at the lower edge of the liver and pancreatic head (orange arrow: Pancreas); B: Computed tomography enhancement showing the passage of blood vessels within the tumor, with patchy areas without enhancement and dilated blood vessels in the center (orange arrow: Pancreas); C: Non-contrast-enhanced magnetic resonance imaging in the pancreatic head; D: Magnetic resonance imaging enhanced arterial scan showed patchy enhancement in the center of the lesion and the delayed scan showed non-enhancement in the strip of patchy areas.
Figure 2
Figure 2
Postoperative microscopic images. A: Heterogeneous cells arranged in organoid or chrysanthemum-shaped clusters [Hematoxylin and eosin (HE): 50 ×]; B: Cells with increased nucleoplasmic ratios and eosinophilic cytoplasm (HE: 100 ×); C: Interstitial fibrous tissue proliferation and myxoid degeneration (HE: 200 ×); D: Irregular nuclear membranes. finechromatin.no necrosis formation (HE: 400 ×).
Figure 3
Figure 3
Immunohistochemistry findings. A: Cluster of differentiation 56 (+); B: Chromogranin A (+); C: Antigen identified by monoclonal antibody Ki-67 (+, 2%-3%); D: Synaptophysin (+) (magnification 200 ×).

Similar articles

References

    1. Lam AK. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours. Endocr Pathol. 2017;28:213–227. - PubMed
    1. Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol. 2022;33:90–114. - PubMed
    1. Al Subhi AR, Boyle V, Elston MS. Systematic Review: Incidence of Pheochromocytoma and Paraganglioma Over 70 Years. J Endocr Soc. 2022;6:bvac105. - PMC - PubMed
    1. Disick GI, Palese MA. Extra-adrenal pheochromocytoma: diagnosis and management. Curr Urol Rep. 2007;8:83–88. - PubMed
    1. Hamidi O. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management. Curr Opin Endocrinol Diabetes Obes. 2019;26:146–154. - PubMed

Publication types

LinkOut - more resources